Jakafi 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FCRG3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,586
Award facts
- Contract value 100% obligated
- $49,586.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of JAKAFI 5 mg tablets (60-count packages) with a ceiling value of $49,586.32. This firm fixed-price delivery order was awarded on November 4, 2025, with an ultimate completion date of November 5, 2025, and carries no set-aside designation. The award leverages DMS Pharmaceutical Group's established capabilities as a critical supplier within the federal pharmaceutical supply chain, demonstrating the company's competitive standing in unrestricted federal procurement.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The underlying IDC, valued at $499,999,999 and extending through December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for pharmaceutical products to support Department of Defense medical supply needs globally. As one of multiple regional prime vendor contractors under the broader $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group supplies an extensive portfolio of branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals to military healthcare facilities worldwide, with this specific delivery order contributing to the agency's recurring medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26FCRG3?
SPE2DR26FCRG3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26FCRG3 worth?
The government has obligated $49,586 on SPE2DR26FCRG3.
Is contract SPE2DR26FCRG3 an order under another contract?
Yes. SPE2DR26FCRG3 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRG3 competed?
The extent of competition for SPE2DR26FCRG3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award